Skip navigation

Policy 0070 • Data Anonymization • Lay Summaries • Patient-Level Data Disclosure • International Registries

January 30-31, 2018
  • Philadelphia, PA

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Examine the impact of Title VIII of FDAAA on the industry
  • Improve your understanding for the changing European
    transparency landscape and what the future holds
  • Learn to strengthen partnerships with advocacy groups
    to improve overall patient value
  • Navigate TransCelerate’s Data Transparency Initiative
    to better harmonize clinical trial processes
  • Hear multi-stakeholder perspectives on
    documentation preparation for Policy 0070

Download the Conference Preview

Previous Attendee Acclaim:

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

January 30-31, 2018 Philadelphia

Clinical Data Disclosure and Transparency

Policy 0070 • Data Anonymization • Lay Summaries • Patient-Level Data Disclosure • International Registries

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Examine the impact of Title VIII of FDAAA on the industry
  • Improve your understanding for the changing European
    transparency landscape and what the future holds
  • Learn to strengthen partnerships with advocacy groups
    to improve overall patient value
  • Navigate TransCelerate’s Data Transparency Initiative
    to better harmonize clinical trial processes
  • Hear multi-stakeholder perspectives on
    documentation preparation for Policy 0070

Download the Conference Preview

Previous Attendee Acclaim:

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

January 30-31, 2018 Philadelphia